• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM27 的表达与鼻腔鼻窦黏膜黑色素瘤的不良预后相关。

TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.

出版信息

Rhinology. 2023 Jun 1;61(3):263-271. doi: 10.4193/Rhin22.405.

DOI:10.4193/Rhin22.405
PMID:36891983
Abstract

BACKGROUND

Tripartite motif-containing 27 (TRIM27) has been implicated in the progression of various cancers. However, the role of TRIM27 in sinonasal mucosal melanoma (SNMM) remains poorly understood.

MATERIALS & METHODS: We retrospectively examined 28 patients with SNMM treated with between 2003 and 2021. We undertook immunohistochemical analysis of TRIM27, Ki-67, and p-Akt1 expression in SNMM tissues. We also investigated the relationship between TRIM27 expression and clinical characteristics, prognosis, Ki-67 as a tumor growth potential marker, and p-Akt1 as one of the prognostic factors in mucosal melanoma.

RESULTS

TRIM27 expression was significantly higher in T4 disease than in T3 disease and was higher in stage IV than in stage III. Patients with high-TRIM27 SNMM had a significantly poorer prognosis in terms of overall survival (OS) and disease-free survival.There was also a significantly higher rate of distant metastasis. Univariate analysis for OS revealed that TRIM27 and T classification were significant poor prognostic factors. In addition, the Ki-67 positive score and the p-Akt1 total staining score were significantly higher in the high-TRIM27 group than in the low-TRIM27 group.

CONCLUSIONS

High TRIM27 expression in SNMM was associated with advanced T classification, poor prognosis and distant metastasis. We suggest that TRIM27 has potential as a novel biomarker for prognosis in SNMM.

摘要

背景

三结构域蛋白 27(TRIM27)已被证实与多种癌症的进展有关。然而,TRIM27 在鼻腔鼻窦黏膜黑色素瘤(SNMM)中的作用仍知之甚少。

材料与方法

我们回顾性地研究了 2003 年至 2021 年间接受治疗的 28 例 SNMM 患者。我们对 SNMM 组织中的 TRIM27、Ki-67 和 p-Akt1 表达进行了免疫组织化学分析。我们还研究了 TRIM27 表达与临床特征、预后、Ki-67 作为肿瘤生长潜能标志物以及 p-Akt1 作为黏膜黑色素瘤预后因素之一之间的关系。

结果

TRIM27 在 T4 期疾病中的表达明显高于 T3 期,在 IV 期疾病中的表达明显高于 III 期。高 TRIM27 SNMM 患者的总生存率(OS)和无病生存率明显较差。远处转移率也明显较高。OS 的单因素分析显示,TRIM27 和 T 分类是显著的不良预后因素。此外,高 TRIM27 组的 Ki-67 阳性评分和 p-Akt1 总染色评分明显高于低 TRIM27 组。

结论

SNMM 中高表达的 TRIM27 与晚期 T 分类、不良预后和远处转移有关。我们认为 TRIM27 可能成为 SNMM 预后的一个新的生物标志物。

相似文献

1
TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma.TRIM27 的表达与鼻腔鼻窦黏膜黑色素瘤的不良预后相关。
Rhinology. 2023 Jun 1;61(3):263-271. doi: 10.4193/Rhin22.405.
2
Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.鼻腔鼻窦黏膜黑色素瘤的淋巴结和远处转移:一项基于人群的分析。
Laryngoscope. 2020 Mar;130(3):622-627. doi: 10.1002/lary.28065. Epub 2019 May 11.
3
Expression of immune checkpoint molecules TIGIT and TIM-3 by tumor-infiltrating lymphocytes predicts poor outcome in sinonasal mucosal melanoma.肿瘤浸润淋巴细胞中免疫检查点分子 TIGIT 和 TIM-3 的表达预示着鼻窦黏膜黑色素瘤预后不良。
Pathol Res Pract. 2024 Aug;260:155468. doi: 10.1016/j.prp.2024.155468. Epub 2024 Jul 14.
4
Sinonasal Mucosal Melanoma: Role of Tumor Proliferative Indices and Pathological Factors in Survival.鼻腔鼻窦黏膜黑色素瘤:肿瘤增殖指数和病理因素对生存率的作用。
Laryngoscope. 2022 Dec;132(12):2350-2358. doi: 10.1002/lary.30240. Epub 2022 Jun 6.
5
Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.原发性肿瘤体积作为鼻窦黏膜黑色素瘤患者远处转移和生存的预测指标。
Head Neck. 2020 Nov;42(11):3316-3325. doi: 10.1002/hed.26380. Epub 2020 Aug 1.
6
Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.法国头颈部黏膜黑色素瘤的肿瘤学结果、预后因素分析和治疗算法评估。
Eur J Cancer. 2019 Dec;123:1-10. doi: 10.1016/j.ejca.2019.09.007. Epub 2019 Oct 24.
7
Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma.TYRP1、ABCB5 和 MMP17 在鼻腔鼻窦黏膜黑色素瘤中的表达及临床意义。
Cancer Biomark. 2022;35(3):331-342. doi: 10.3233/CBM-220093.
8
Characterization of the tumor-infiltrating lymphocyte landscape in sinonasal mucosal melanoma.鼻窦黏膜黑色素瘤中肿瘤浸润淋巴细胞景观的特征分析
Pathol Res Pract. 2023 Jan;241:154289. doi: 10.1016/j.prp.2022.154289. Epub 2022 Dec 26.
9
Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.治疗方式在鼻腔鼻窦黏膜黑色素瘤:国家癌症数据库分析。
Laryngoscope. 2020 Feb;130(2):275-282. doi: 10.1002/lary.27995. Epub 2019 Apr 25.
10
Prognostic Value of Tumor-Infiltrating Lymphocytes in Sinonasal Mucosal Melanoma.肿瘤浸润淋巴细胞在鼻腔鼻窦黏膜黑色素瘤中的预后价值。
Laryngoscope. 2022 Jul;132(7):1334-1339. doi: 10.1002/lary.29820. Epub 2021 Aug 20.

引用本文的文献

1
Survival Outcomes in Sinonasal Mucosal Melanoma: Systematic Review and Meta-Analysis.鼻窦黏膜黑色素瘤的生存结局:系统评价与荟萃分析
J Pers Med. 2024 Nov 26;14(12):1120. doi: 10.3390/jpm14121120.
2
Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients.多种细胞死亡模式可预测黑色素瘤患者的预后和药物敏感性。
Front Pharmacol. 2024 Oct 8;15:1295687. doi: 10.3389/fphar.2024.1295687. eCollection 2024.
3
Skull Base Tumors: Therapeutic Challenges and Multi-Disciplinary Care.颅底肿瘤:治疗挑战与多学科护理
Cancers (Basel). 2024 Jan 31;16(3):620. doi: 10.3390/cancers16030620.